Laboratório Sabin de Análises Clínicas S.A., commonly referred to as Sabin, is a leading player in the Brazilian healthcare sector, headquartered in Brasília, Brazil. Founded in 1968, the laboratory has established a strong presence across various regions, providing high-quality clinical analysis services. Specialising in diagnostic testing, Sabin offers a comprehensive range of services, including laboratory tests, preventive medicine, and health management solutions. The company is renowned for its commitment to innovation and quality, utilising advanced technology to ensure accurate and timely results. With a robust market position, Sabin has achieved significant milestones, including numerous certifications and recognitions for excellence in healthcare. Its dedication to patient care and operational efficiency has solidified its reputation as a trusted name in clinical diagnostics throughout Brazil.
How does Laboratório Sabin de Análises Clínicas S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laboratório Sabin de Análises Clínicas S.A.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laboratório Sabin de Análises Clínicas S.A. currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. This lack of data suggests that the company may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the clinical analysis industry, many organisations are increasingly focusing on sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Laboratório Sabin's position relative to industry standards or its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Laboratório Sabin de Análises Clínicas S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

